Endogenous and synthetic agonists of GPR119 differ in signalling pathways and their effects on insulin secretion in MIN6c4 insulinoma cells
about
International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligandsReceptors for acylethanolamides-GPR55 and GPR119Update on the treatment of type 2 diabetes mellitusGPR119 agonists for the treatment of type 2 diabetesPharmacological elevation of anandamide impairs short-term memory by altering the neurophysiology in the hippocampus.The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptorsN-oleoyldopamine enhances glucose homeostasis through the activation of GPR119.A GPR119 Signaling System in the Murine Eye Regulates Intraocular Pressure in a Sex-Dependent MannerElevation of endogenous anandamide impairs LTP, learning, and memory through CB1 receptor signaling in mice.Lipid receptors and islet function: therapeutic implications?Discovery and characterization of novel small molecule agonists of G protein-coupled receptor 119.Functional metagenomic discovery of bacterial effectors in the human microbiome and isolation of commendamide, a GPCR G2A/132 agonistSimvastatin Impairs Insulin Secretion by Multiple Mechanisms in MIN6 Cells.Endogenous Ligand for GPR120, Docosahexaenoic Acid, Exerts Benign Metabolic Effects on the Skeletal Muscles via AMP-activated Protein Kinase Pathway.Free fatty acid receptors: emerging targets for treatment of diabetes and its complications.Lipid derivatives activate GPR119 and trigger GLP-1 secretion in primary murine L-cells.Gustducin couples fatty acid receptors to GLP-1 release in colon.A lincRNA-DYNLRB2-2/GPR119/GLP-1R/ABCA1-dependent signal transduction pathway is essential for the regulation of cholesterol homeostasisCannabis sativa and the endogenous cannabinoid system: therapeutic potential for appetite regulation.The therapeutic potential of GPR119 agonists for type 2 diabetes.Is GPR119 agonism an appropriate treatment modality for the safe amelioration of metabolic diseases?G protein-coupled receptors in energy homeostasis.Gastrointestinal hormonal responses on GPR119 activation in lean and diseased rodent models of type 2 diabetes.Therapeutic application of GPR119 ligands in metabolic disorders.G protein-coupled receptors: signalling and regulation by lipid agonists for improved glucose homoeostasis.Modulation of Glucagon-like Peptide-1 (GLP-1) Potency by Endocannabinoid-like Lipids Represents a Novel Mode of Regulating GLP-1 Receptor Signaling.Evaluation of the insulin releasing and antihyperglycaemic activities of GPR55 lipid agonists using clonal beta-cells, isolated pancreatic islets and miceStructural basis for constitutive activity and agonist-induced activation of the enteroendocrine fat sensor GPR119.The cytoprotective effects of oleoylethanolamide in insulin-secreting cells do not require activation of GPR119.Agonists at GPR119 mediate secretion of GLP-1 from mouse enteroendocrine cells through glucose-independent pathways.GPR119 regulates murine glucose homeostasis through incretin receptor-dependent and independent mechanismsGPR119 is essential for oleoylethanolamide-induced glucagon-like peptide-1 secretion from the intestinal enteroendocrine L-cell.Cannabinoids Modulate Neuronal Activity and Cancer by CB1 and CB2 Receptor-Independent Mechanisms.Chemistry and Hypoglycemic Activity of GPR119 Agonist ZB-16
P2860
Q24605072-3408E1B8-5D61-4E53-AD84-51AF18E870EEQ24647538-454F1FA0-B979-43E3-AB0D-B473957DB0E6Q28073342-D0EBEA0F-DCD9-4E27-9D2A-A400BCA1F999Q28259606-BA3FF7B1-45DC-4DA9-9690-3A30E50B7863Q30463112-A545656D-FDDB-4703-AB02-B48A34BD0630Q30486707-FAC741CE-02B7-4244-B274-76AA6EBB3EADQ33670471-5C37DD4A-E192-40B4-9B7C-4E00261D9AE2Q33792933-78E6A73A-D8D8-4EE3-9BD1-90A49B617ADBQ33829479-16AD133F-EFCE-48A5-AC3D-811DAD884E50Q33930824-58C11C44-1281-4570-A313-FCF9C5E90D1AQ35135054-DBF5D495-9068-4F40-8EE9-4B57AB4B5196Q35748377-CE511949-5D5B-4B01-8B9C-93E702298297Q35839578-3FBF5F4C-1E44-4540-B849-53F75414CA78Q35953181-122C2892-159A-4916-A92D-B13C0003024BQ36327956-EF76BF8F-59B1-42C0-9F71-58067543098BQ36677839-7529A8E6-0D3C-4243-9F14-BD8AB58BAC3BQ36699764-1B124AF2-3105-476C-9B51-985C12F069B1Q37665457-91857792-BA38-4B98-AE0B-5E529E0C67AEQ37826693-4D0B1E11-CECC-4D6C-B50C-F827AE71E194Q37980173-EEAEF2C8-94D9-4902-B5E1-70BF5C9D204CQ38084735-0765B839-3120-461E-9F7B-3AB2E8AA51BAQ38223619-2364E53F-EA01-4471-B4AF-2B036E71A7EEQ38309551-BCAC1C4E-72CB-46B0-A872-AC0B0810BBE7Q38655382-FEE7CE18-26E5-4650-AD23-17C399D0DF60Q38688833-58E4AA59-AA72-478F-9004-848027827C21Q38883453-C60E5EF1-5497-4E0D-A992-3BCD395E6D69Q39102543-D0136350-3C32-4097-A7B2-B71FFDBDDD42Q39145769-53EA4599-86ED-4FEC-9A0E-73BB89A91DDAQ39452243-DBA9C38E-7868-4B78-AED9-628339317D47Q39452270-B832F7D3-E559-4C7F-BC88-CB046BDBE5EAQ41962105-4C7EE773-3F72-446B-B7AE-3D80665133F9Q42146257-03CA17A6-77AD-4E39-A4C5-8A504E1BBBB0Q42700473-A55209B6-A74A-4D23-99A4-71080701555BQ57072608-0FD1F99C-98B5-4F2B-8492-4A16AC910BFD
P2860
Endogenous and synthetic agonists of GPR119 differ in signalling pathways and their effects on insulin secretion in MIN6c4 insulinoma cells
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Endogenous and synthetic agoni ...... ion in MIN6c4 insulinoma cells
@ast
Endogenous and synthetic agoni ...... ion in MIN6c4 insulinoma cells
@en
Endogenous and synthetic agoni ...... ion in MIN6c4 insulinoma cells
@nl
type
label
Endogenous and synthetic agoni ...... ion in MIN6c4 insulinoma cells
@ast
Endogenous and synthetic agoni ...... ion in MIN6c4 insulinoma cells
@en
Endogenous and synthetic agoni ...... ion in MIN6c4 insulinoma cells
@nl
prefLabel
Endogenous and synthetic agoni ...... ion in MIN6c4 insulinoma cells
@ast
Endogenous and synthetic agoni ...... ion in MIN6c4 insulinoma cells
@en
Endogenous and synthetic agoni ...... ion in MIN6c4 insulinoma cells
@nl
P2093
P2860
P356
P1476
Endogenous and synthetic agoni ...... ion in MIN6c4 insulinoma cells
@en
P2093
J A Hedrick
P2860
P304
P356
10.1038/BJP.2008.337
P407
P577
2008-12-01T00:00:00Z